Pneumococcal 20-Valent Conjugate Vaccine（Beijing Minhai Biotech）

20价肺炎球菌多糖结合疫苗（北京民海生物）

Report date: 2025/12/29 15:30:20

Base Information

Drug NamePneumococcal 20-Valent Conjugate Vaccine（Beijing Minhai Biotech）
Drug Alias Name20-Valent Pneumococcal Conjugate Vaccine（Jiangsu Kunli）20价肺炎疫苗（北京民海生物）
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Vaccine type > Multivalent vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumonia, PneumococcalPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumonia, PneumococcalPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A